Stay updated on Lenvatinib Plus Pembrolizumab in Hepatocellular Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Lenvatinib Plus Pembrolizumab in Hepatocellular Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenvatinib Plus Pembrolizumab in Hepatocellular Carcinoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0 while the study page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T22:27:23.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    A site-wide notice announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” and links to transition updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T22:29:00.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.1 to v3.7.2 while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T22:32:05.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The site footer revision identifier changed from v3.7.0 to v3.7.1; the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-10T22:21:14.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error with basic site chrome, replacing the previous study record content and indicating an access-denied state.
    Difference
    21%
    Check dated 2026-09-19T22:01:16.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    The study record now includes an NIH funding note (2018) in the identifiers section, indicating U.S. NIH support for the trial. The page's revision line was updated to Revision: v3.6.6, replacing the older v3.6.5 tag.
    Difference
    0.1%
    Check dated 2026-08-29T21:48:21.000Z thumbnail image

Stay in the know with updates to Lenvatinib Plus Pembrolizumab in Hepatocellular Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenvatinib Plus Pembrolizumab in Hepatocellular Carcinoma Clinical Trial page.